##common.pageHeaderLogo.altText##

Vol. 3 No. 4 (2023)

A Comprehensive Review on Down Syndrome Diagnosis and Associated Genes: Diagnosis of DS

Clinical Medicine And Health Research Journal, Vol. 3 No. 4 (2023), 15 August 2023 , Page 495-498
https://doi.org/10.18535/cmhrj.v3i4.210

Abstract

Down syndrome (DS) is an inherited genetic disease characterized with the trisomy of chromosome 21. The major clinical presentation of DS is intellectual disability which is seen among 12-15% of DS patients in the developed countries. Increased maternal age over 30 years increases the risk of having DS child. DS affects various organ systems causing cardiac disorders, GI abnormalities, hematological anomalies, endocrine disorders and skin diseases along with morphological anomalies of face, feet and hands. The current review aims at outlining the genes associated with cardiac, GI and hematological disorders seen in DS patients along with DS itself and also widely used diagnostic tools in identifying the disorder.

Keywords:
  • Down syndrome
  • Gene Mapping
  • Genotype-Phenotype correlation
  • Genetics
  • Chromosome 21
  • Trisomy

How to Cite

Sattoju, D. N. . (2023). A Comprehensive Review on Down Syndrome Diagnosis and Associated Genes: Diagnosis of DS. Clinical Medicine And Health Research Journal, 3(4), 495–498. https://doi.org/10.18535/cmhrj.v3i4.210

Download Citation

References

  • Akhtar F, Bokhari SRA. Down Syndrome. The 5-Minute Pediatric Consult, 8th Edition. Published online December 12, 2021:306-307.
  • Holmes G. Gastrointestinal disorders in Down syndrome. Gastroenterol Hepatol Bed Bench. 2014;7(1):6. [Cited 2022 Aug.26]. Available from: /pmc/articles/PMC4017552/
  • AH B, EJ G. Clinical, social, and ethical implications of changing life expectancy in Down syndrome. Dev Med Child Neurol. 2004;46(4).
  • Verma IC, Bijarnia S. The burden of genetic disorders in India and a framework for community control. Community Genet. 2002;5(3):192-196.
  • Mutton D, Alberman E, Hook EB. Cytogenetic and epidemiological findings in Down syndrome, England and Wales 1989 to 1993. National Down Syndrome Cytogenetic Register and the Association of Clinical Cytogeneticists. J Med Genet. 1996;33(5):387-394.
  • Bermudez BEBV, de Oliveira CM, de Lima Cat MN, Magdalena NIR, Celli A. Gastrointestinal disorders in Down syndrome. Am J Med Genet A. 2019;179(8):1426-1431.
  • Maslen CL, Babcock D, Robinson SW, Bean LJH, Dooley KJ, Willour VL, et al. CRELD1 mutations contribute to the occurrence of cardiac atrioventricular septal defects in Down syndrome. Am J Med Genet A. 2006;140A(22):2501-2505.
  • Kava MP, Tullu MS, Muranjan MN, Girisha KM. Down syndrome: clinical profile from India. Arch Med Res. 2004;35(1):31-35.
  • Zheng CG, Qin J, Du J, Chen K, Chen C, Tian XX, et al. [Cytogenetic study of Down syndrome cases in Nanning, China]. Yi Chuan. 2009;31(3):261-264.
  • MacLennan DS. Down’s syndrome. https://doi.org/101177/1755738019886612. 2019;13(1):47-52.
  • Roizen NJ, Patterson D. Down’s syndrome. Lancet. 2003;361(9365):1281-1289.
  • Asim A, Kumar A, Muthuswamy S, Jain S, Agarwal S. “Down syndrome: an insight of the disease.” J Biomed Sci. 2015;22(1).
  • Lyle R, Béna F, Gagos S, Gehrig C, Lopez G, Schinzel A, et al. Genotype–phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21. European Journal of Human Genetics. 2009;17(4):454.
  • Antonarakis SE, Lyle R, Dermitzakis ET, Reymond A, Deutsch S. Chromosome 21 and Down syndrome: from genomics to pathophysiology. Nature Reviews Genetics 2004 5:10. 2004;5(10):725-738.
  • Korenberg JR, Chen XN, Schipper R, Sun Z, Gonsky R, Gerwehr S, et al. Down syndrome phenotypes: the consequences of chromosomal imbalance. Proceedings of the National Academy of Sciences. 1994;91(11):4997-5001.
  • The “gene dosage effect” hypothesis versus the “amplified developmental instability” hypothesis in Down syndrome - PubMed. [Cited 2022 Aug.27]. Available from: https://pubmed.ncbi.nlm.nih.gov/10666684/
  • Delabar JM, Theophile D, Rahmani Z, Chettouh Z, Blouin JL, Prieur M, et al. Molecular Mapping of Twenty-Four Features of Down Syndrome on Chromosome 21. European Journal of Human Genetics 1993 1:2. 1993;1(2):114-124.
  • Korenberg JR, Kawashima H, Pulst MS, Allen L, Magenis E, Epstein CJ. Down syndrome: Toward a molecular definition of the phenotype. Am J Med Genet. 1990;(SUPPL. 7):91-97.
  • McCormick MK, Schinzel A, Petersen MB, Stetten G, Driscoll DJ, Cantu ES, et al. Molecular genetic approach to the characterization of the “Down syndrome region” of chromosome 21. Genomics. 1989;5(2):325-331.
  • Korenberg JR, Kawashima H, Pulst MS, Allen L, Magenis E, Epstein CJ. Down syndrome: Toward a molecular definition of the phenotype. Am J Med Genet. 1990;(SUPPL. 7):91-97.
  • Sinet PM, Théophile D, Rahmani Z, Chettouh Z, Blouin JL, Prieur M, et al. Mapping of the Down syndrome phenotype on chromosome 21 at the molecular level. Biomed Pharmacother. 1994;48(5-6):247-252.
  • Choi JK. Hematopoietic Disorders in Down Syndrome. Int J Clin Exp Pathol. 2008;1(5):387. [Cited 2022 Aug.27]. Available from: /pmc/articles/PMC2480572/
  • Maslen CL, Babcock D, Robinson SW, Bean LJH, Dooley KJ, Willour VL, et al. CRELD1 mutations contribute to the occurrence of cardiac atrioventricular septal defects in
  • Down syndrome. Am J Med Genet A. 2006;140(22):2501-2505.
  • Barlow GM, Chen XN, Shi ZY, Lyons GE, Kurnit DM, Celle L, et al. Down syndrome congenital heart disease: a narrowed region and a candidate gene. Genet Med. 2001;3(2):91-101.
  • Rupp PA, Fouad GT, Egelston CA, Reifsteck CA, Olson SB, Knosp WM, et al. Identification, genomic organization and mRNA expression of CRELD1, the founding member of a unique family of matricellular proteins. Gene. 2002;293(1-2):47-57.
  • Robinson SW, Morris CD, Goldmuntz E, Reller MD, Jones MA, Steiner RD, et al. Missense Mutations in CRELD1 Are Associated with Cardiac Atrioventricular Septal Defects. Am J Hum Genet. 2003;72(4):1047.
  • MRI brain changes in subjects with Down syndrome with and without dementia - PubMed. [Cited 2022 Aug.28]. Available from: https://pubmed.ncbi.nlm.nih.gov/9630260/
  • Lott IT. Neurological phenotypes for Down syndrome across the life span. Prog Brain Res. 2012;197:101.
  • Coyle JT, Oster-Granite ML, Gearhart JD. The neurobiologic consequences of Down syndrome. Brain Res Bull. 1986;16(6):773-787.
  • Jones EL, Mok K, Hanney M, Harold D, Sims R, Williams J, et al. Evidence that PICALM affects age at onset of Alzheimer’s dementia in Down syndrome. Neurobiol Aging. 2013;34(10):2441.e1.
  • Berrocal T, Lamas M, Gutiérrez J, Torres I, Prieto C, del Hoyo ML. Congenital anomalies of the small intestine, colon, and rectum. Radiographics. 1999;19(5):1219-1236.
  • Holmes G. Gastrointestinal disorders in Down syndrome. Gastroenterol Hepatol Bed Bench. 2014;7(1):6. [Cited 2022 Sep.14]. Available from: /pmc/articles/PMC4017552/
  • Mårild K, Stephansson O, Grahnquist L, Cnattingius S, Söderman G, Ludvigsson JF. Down syndrome is associated with elevated risk of celiac disease: a nationwide case-control study. J Pediatr. 2013;163(1):237-242.
  • Wallace RA. Clinical audit of gastrointestinal conditions occurring among adults with Down syndrome attending a specialist clinic. J Intellect Dev Disabil. 2007;32(1):45-50.
  • Levy J. The gastrointestinal tract in Down syndrome. Prog Clin Biol Res. 1991;373:245-256. [Cited 2022 Sep.14]. Available from: https://europepmc.org/article/med/1838188
  • Henry E, Walker D, Wiedmeier SE, Christensen RD. Hematological abnormalities during the first week of life among neonates with Down syndrome: data from a multihospital healthcare system. Am J Med Genet A. 2007;143A(1):42-50.
  • Webb D, Roberts I, Vyas P. Haematology of Down syndrome. Arch Dis Child Fetal Neonatal Ed. 2007;92(6):F503.
  • Miller M, Cosgriff JM. Hematological abnormalities in newborn infants with Down syndrome. Am J Med Genet. 1983;16(2):173-177.
  • Wechsler J, Greene M, McDevitt MA, Anastasi J, Karp JE, le Beau MM, et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet. 2002;32(1):148-152.
  • Renna MD, Pisani P, Conversano F, Perrone E, Casciaro E, Renzo GC di, et al. Sonographic markers for early diagnosis of fetal malformations. World J Radiol. 2013;5(10):356.
  • Wald NJ, Bestwick JP. Incorporating DNA Sequencing into Current Prenatal Screening Practice for Down’s Syndrome. PLoS One. 2013;8(3).
  • Nicolaides KH. Screening for chromosomal defects. Ultrasound in Obstetrics and Gynecology. 2003;21(4):313-321.
  • Jain S, Agarwal S, Panigrahi I, Tamhankar P, Phadke S. Diagnosis of Down syndrome and detection of origin of nondisjunction by short tandem repeat analysis. Genet Test Mol Biomarkers. 2010;14(4):489-491.
  • Chim SSC, Jin S, Lee TYH, Lun FMF, Lee WS, Chan LYS, et al. Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21. Clin Chem. 2008;54(3):500-511.
  • What are common symptoms of Down syndrome? | NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development. [Cited 2022 Aug.28]. Available from: https://www.nichd.nih.gov/health/topics/down/conditioninfo/symptoms
  • Facts about Down Syndrome | CDC. [Cited 2022 Aug.28]. Available from: https://www.cdc.gov/ncbddd/birthdefects/downsyndrome.html
    • Article Viewed: 0 Total Download

    ##plugins.themes.ojsPlusA.frontend.article.downloadstatastics##

    Cover Image

    Information